New Developments in Carbonic Anhydrase IX-Targeted Fluorescence and Nuclear Imaging Agents
Carbonic anhydrase IX (CAIX) is a tumor-specific and hypoxia-induced biomarker for the molecular imaging of solid malignancies. The nuclear- and optical-imaging of CAIX-expressing tumors have received great attention due to their potential for clinical applications. Nuclear imaging is a powerful too...
Main Authors: | Kuo-Ting Chen, Yann Seimbille |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/11/6125 |
Similar Items
-
Isolation and characterization of monoclonal antibodies against human carbonic anhydrase-IX
by: Anne E.G. Lenferink, et al.
Published: (2021-01-01) -
An update on anticancer drug development and delivery targeting carbonic anhydrase IX
by: Justina Kazokaitė, et al.
Published: (2017-11-01) -
Indocyanine Green-Loaded Nanobubbles Targeting Carbonic Anhydrase IX for Multimodal Imaging of Renal Cell Carcinoma
by: Zhong C, et al.
Published: (2023-05-01) -
Expression and prognostic value of carbonic anhydrase IX (CA-IX) in bladder urothelial carcinoma
by: An-Ping Xiang, et al.
Published: (2022-08-01) -
Targeting Carbonic Anhydrase IX Activity and Expression
by: Brian P. Mahon, et al.
Published: (2015-01-01)